Fenmetozole

This classification denotes an antidepressant agent with the molecular formula C10H10Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C15WFN6GMO, chemically known as 1h-imidazole, 2-((3,4-dichlorophenoxy)methyl)-4,5-dihydro- but generally known as fenmetozole, which bears US NIH Compound Identifier 32049. European Medicines Agency schedules Fenmetozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07571MIG. The term FENMETOZOLE is an International Non-Proprietary Name. FENMETOZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenmetozole under HS 29332990 and SITC 51573. As of Q4 2014, FENMETOZOLE remains the US FDA Preferred Term for this commodity. Fenmetozole bears US NLM identifiers UMLS ID C0060175 and NCI Concept Code C81487. SMILES: C1CN=C(N1)COC2=CC(=C(C=C2)Cl)Cl.